Skip to product information
1 of 1

PerCP-Cy5.5 Mouse Anti-Human CD3ε Antibody (HIT3a)

PerCP-Cy5.5 Mouse Anti-Human CD3ε Antibody (HIT3a)

Catalog Number: S0B8233 Application: FCM Reactivity: Hu Conjugation: PerCP-Cy5.5 Brand: Starter
Price:
Regular price $146 USD
Regular price Sale price $146 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Synonyms T-cell surface glycoprotein CD3 epsilon chain; T-cell surface antigen T3/Leu-4 epsilon chain; T3E; CD3E
Location Cell membrane
Accession P07766
Clone Number HIT3a
Antibody Type Mouse mAb
Isotype IgG2a
Application FCM
Reactivity Hu
Purification Protein A
Concentration 0.2 mg/ml
Conjugation PerCP-Cy5.5
Physical Appearance Liquid
Storage Buffer

PBS, 1% BSA, 0.3% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 5μl per million cells in 100μl volume Hu

Background

CD3ε is a subunit of the CD3 complex, which is a critical component of the T-cell receptor (TCR) complex on T cells. Together with CD3γ, CD3δ, and CD3ζ, it forms the TCR-CD3 complex that plays a vital role in coupling antigen recognition to intracellular signaling pathways. This complex is essential for T cell activation, proliferation, and differentiation. CD3ε contains an extracellular immunoglobulin domain, a transmembrane region, and a cytoplasmic tail with an immunoreceptor tyrosine-based activation motif (ITAM). Upon antigen recognition, the ITAMs in CD3ε are phosphorylated, initiating downstream signaling cascades that lead to T cell activation. Additionally, CD3ε interacts with other signaling molecules like Lck and Nck through its unique motifs, further modulating T cell responses. Its importance in T cell function makes CD3ε a target for immunotherapies, including cancer treatments and autoimmune disease management.

Picture

FC

Flow cytometric analysis of Human CD3ε expression on human peripheral blood leukocytes. Human peripheral blood leukocytes were stained with Brilliant Violet 421™ Mouse Anti-Human CD19 antibody and either PerCP-Cy5.5 Mouse IgG2a Isotype Control (Left panel) or SDT PerCP-Cy5.5 Mouse Anti-Human CD3ε Antibody (Right panel) at 5 μl/test treated with True-Stain Monocyte Blocker™. Total viable cells, as determined by Fixable Viability Dye 515 (S0D0013), were used for analysis. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.